We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Ferring Petition: FDA Interpreted Hatch-Waxman Wrong
Ferring Petition: FDA Interpreted Hatch-Waxman Wrong
February 8, 2013
Ferring Pharmaceuticals is petitioning the FDA for five-year exclusivity on its colonoscopy prep drug Prepopik.